Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis;Ocena zależności pomiędzy leptyną, rezystyną i adiponektyną a naturalnymi limfocytami regulatorowymi t w postaci nawracająco-zwalniającej stwardnienia rozsianego

Neurologia i Neurochirurgia Polska

Volumn 46, Issue 1, 2012, Pages 22-28

  Kraszula, Łukasz ^a   Jasińska, Anna ^a   Eusebio, Makandjou Ola ^a   Kuna, Piotr ^a   Głabiński, Andrzej ^a   Pietruczuk, Mirosława ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Adiponectin; FoxP3; Leptin; Multiple sclerosis; Natural regulatory T cells (nTreg); Resistin

Indexed keywords

ADIPONECTIN; CD4 ANTIGEN; CORTICOSTEROID; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; LEPTIN; METHYLPREDNISOLONE; RESISTIN; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MULTIPLE SCLEROSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

EID: 84858839512     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.5114/ninp.2012.27211     Document Type: Article

References (35)

1. Constantino C.M., Hutton J., Baecher-Allan C., et al. Multiple sclerosis and regulatory T cells. J Clin Immunol 2008; 28: 697-706.
2. Selmaj K. Stwardnienie rozsiane. Termedia, Poznań 2006.
3. Korn T., Anderson A.C., Bettelli E., et al. The dynamics of effector T cells and Foxp3 regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis. J Neuroimmunol 2007; 191: 51-60.
4. Kimura A., Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 2010; 40: 1830-1835.
5. De Rosa V., Procaccini C., Cali G., et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007; 26: 241-255.
6. Fletcher J.M., Lalor S.J., Sweeney C.M., et al. T cells in multiple sclerosis and experimental autoimmune encephalo myelitis. Clin Exp Immunol 2010; 162: 1-11.
7. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Immunology 2006; 6: 772-783.
8. Askenasy N., Kaminitz A., Yarkoni S. Mechanism of T regulatory cell function. Autoimmunity Rev 2008; 7: 370-375.
9. Astier A.L., Meiffren G., Freeman S. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest 2006; 116: 3252-3257.
10. Astier A.L., Hafler D.A. Abnormal Tr1 differentiation in multiple sclerosis. J Neuroimmunol 2007; 191: 70-78.
11. + regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol 2007; 147: 412-418.
12. Viglietta V., Baecher-Allan C., Weiner H.L., et al. Loss functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-979.
13. + T cells in multiple sclerosis: relative lack of suppressive populations in blond. Mult Scler 2011; 17: 57-66.
14. Frisullo G., Angelucci F., Mirabella M., et al. Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients. J Clin Immunol 2004; 24: 287-293.
15. Guzik T.J., Mangalat D., Korbut R. Adipocytokines - novel link between inflammation and vascular function? J Physiol Pharmacol 2006; 57: 5028-5065.
16. Largo F., Dieguez C., Gómez-Reino J., et al. The emerging role of adipokines as mediators of inflammation and immune responses. Cyt Grow Fac Rev 2007; 18: 313-325.
17. Meier U., Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525.
18. Batocchi A.P., Rotondi M., Caggiula M.I., et al. Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. J Neuroimmunol 2003; 139: 150-154.
19. Bernotiene E., Palmer G., Gabay C. The role leptin in innate and adaptive immune responses. Arthritis Res Ther 2006; 8: 1-10.
20. Hasenkrug K.J. The leptin connection: regulatory T cells and autoimmunity. Immunity 2007; 26: 143-145.
21. Matarese G., Procaccini C., De Rosa V. The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis? J Leukoc Biol 2008; 84: 893-899.
22. Bokarewa M., Nagaev I., Dahlberg., et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789-5795.
23. Karbowska A., Boratyńska M., Klinger M. Resistin: a pathogenic factor or a biomarker of metabolic disorders and infla - mmation? Postepy Hig Med Dosw 2009; 23: 485-491.
24. Koerner A., Kratzsch J., Kiess W. Adipocytokines: leptin - the classical, resistin - the controversical, adiponectin - the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005; 19: 525-546.
25. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-127.
26. Compston A., Coles A. Multiple sclerosis. Lancet 2008; 372: 1502-1517.
27. + regulatory T cells. PNAS 2005; 102: 5150-5155.
28. Cimmino M.A., Andraghetti G., Briatore L., et al. Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica. Ann N Y Acad Sci 2010; 1193: 160-163.
29. Noriko I., Queenie L.K., Liwei L., et al. Leptin and infla mmation. Curr Immunol Rev 2008; 4: 70-79.
30. + Foxp3+T lymphocytes fail to supress myelin basic proteininduced proliferation in patients with multiple sclerosis. J Neuroimmunol 2006; 180: 178-184.
31. Putheti P., Petterson A., Soderstrom M., et al. Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease - modulating drugs. J Clin Immunol 2004; 24: 155-161.
32. Unsong O., Blevins G., Griffith C., et al. Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis. Arch Neurol 2009; 66: 471-479.
33. Bacchetta R., Gambineri E., Roncarolo M.G. Role of regulatory T cells and FoxP3 in human diseases. J Allergy Clin Immunol 2007; 120: 227-235.
34. Karagiannidis C., Akdis M., Holopainen P., et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114: 1425-1433.
35. Kraszula Ł., Eusebio M.O., Kupczyk M., et al. Naturalne regulatorowe limfocyty T u chorych na astme{ogonek} oskrzelowa{ogonek}. J Lab Diagn 2010; 46: 313-318.